• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相模霉素及相关氨基糖苷类抗生素:发酵与生物合成。III. 庆大霉素C1途径受阻的相模小单孢菌突变体的分离与特性鉴定

Sagamicin and the related aminoglycosides: fermentation and biosynthesis. III. Isolation and characterization of Micromonospora sagamiensis mutants blocked in gentamicin C1 pathway.

作者信息

Odakura Y, Kase H, Nakayama K

出版信息

J Antibiot (Tokyo). 1983 Feb;36(2):125-30. doi: 10.7164/antibiotics.36.125.

DOI:10.7164/antibiotics.36.125
PMID:6833127
Abstract

Production of sagamicin and gentamicin C1 in Micromonospora sagamiensis was regulated by cobalt ion. In a parental strain, KY11510, cobalt ion stimulated gentamicin C1 production and suppressed sagamicin production. By ultraviolet light or N-methyl-N'-nitro-N-nitrosoguanidine treatment, six mutants blocked in gentamicin C1 biosynthesis were obtained from KY11510. These mutants were classified into two types. The first type, four mutants, produced no gentamicin C1 even when cobalt ion was added to the fermentation. The second type, two mutants, produced a small amount of gentamicin C1 when a high concentration of cobalt ion was added. Based on biotransformation experiments, these mutants appeared to be blocked at the 6'-C-methylation step in the biosynthesis of gentamicin C1. The mutants showed an increased production of sagamicin. In addition, cobalt ion stimulated sagamicin production in the mutants. The mechanism of cobalt regulation in the parent and the mutants is discussed.

摘要

相模湾小单孢菌中相模霉素和庆大霉素C1的产生受钴离子调控。在亲本菌株KY11510中,钴离子刺激庆大霉素C1的产生并抑制相模霉素的产生。通过紫外线或N-甲基-N'-硝基-N-亚硝基胍处理,从KY11510中获得了6个在庆大霉素C1生物合成中受阻的突变体。这些突变体分为两种类型。第一种类型,4个突变体,即使在发酵中添加钴离子也不产生庆大霉素C1。第二种类型,2个突变体,当添加高浓度钴离子时产生少量庆大霉素C1。基于生物转化实验,这些突变体似乎在庆大霉素C1生物合成的6'-C-甲基化步骤受阻。这些突变体相模霉素的产量增加。此外,钴离子刺激突变体中相模霉素的产生。讨论了亲本和突变体中钴调控的机制。

相似文献

1
Sagamicin and the related aminoglycosides: fermentation and biosynthesis. III. Isolation and characterization of Micromonospora sagamiensis mutants blocked in gentamicin C1 pathway.相模霉素及相关氨基糖苷类抗生素:发酵与生物合成。III. 庆大霉素C1途径受阻的相模小单孢菌突变体的分离与特性鉴定
J Antibiot (Tokyo). 1983 Feb;36(2):125-30. doi: 10.7164/antibiotics.36.125.
2
Sagamicin and the related aminoglycosides: fermentation and biosynthesis. I. Biosynthetic studies with the blocked mutants of Micromonospora sagamiensis.相模霉素及相关氨基糖苷类抗生素:发酵与生物合成。I. 相模小单孢菌阻断突变体的生物合成研究。
J Antibiot (Tokyo). 1982 Jan;35(1):1-9. doi: 10.7164/antibiotics.35.1.
3
Synthesis of carbon-14 and tritium labeled sagamicin.
J Antibiot (Tokyo). 1977 Nov;30(11):993-8. doi: 10.7164/antibiotics.30.993.
4
Production of antibiotic SU-2 complex by a 2-deoxystreptamine idiotroph of Micromonospora sagamiensis.
J Antibiot (Tokyo). 1982 Apr;35(4):385-90. doi: 10.7164/antibiotics.35.385.
5
[Role of cobalt in the biosynthesis of the components of the gentamicin complex].[钴在庆大霉素复合物各组分生物合成中的作用]
Antibiotiki. 1978 Jan;23(1):12-8.
6
Biotransformation, a new approach to aminoglycoside biosynthesis: II. Gentamicin.生物转化:氨基糖苷生物合成的一种新方法:II. 庆大霉素
J Antibiot (Tokyo). 1976 Feb;29(2):140-6. doi: 10.7164/antibiotics.29.140.
7
Biosynthesis of 3″-demethyl-gentamicin C components by genN disruption strain of Micromonospora echinospora and test their antimicrobial activities in vitro.通过棘孢小单孢菌的genN基因破坏菌株生物合成3″-去甲基庆大霉素C组分并体外测试其抗菌活性。
Microbiol Res. 2016 Apr;185:36-44. doi: 10.1016/j.micres.2016.01.005. Epub 2016 Jan 28.
8
New antibiotic XK-62-2 (sagamicin). II Taxonomy of the producing organism, fermentative production and characterization of sagamicin.
J Antibiot (Tokyo). 1975 Jan;28(1):21-8. doi: 10.7164/antibiotics.28.21.
9
Antibiotic biosynthesis by cofermentation of blocked mutants of two Micromonospora species.通过两种小单孢菌属的阻断突变体共发酵进行抗生素生物合成。
Antimicrob Agents Chemother. 1978 Jul;14(1):73-7. doi: 10.1128/AAC.14.1.73.
10
Biosynthesis of astromicin and related antibiotics. II. Biosynthetic studies with blocked mutants of Micromonospora olivasterospora.
J Antibiot (Tokyo). 1984 Dec;37(12):1670-80. doi: 10.7164/antibiotics.37.1670.

引用本文的文献

1
D-optimal design model and biosynthetic pathway for gentamicin production by Micromonospora purpureochromogenes NRRL B-16094.用于紫色产色小单孢菌NRRL B-16094生产庆大霉素的D-最优设计模型和生物合成途径
BMC Microbiol. 2025 May 20;25(1):309. doi: 10.1186/s12866-025-04001-8.
2
A comprehensive review of glycosylated bacterial natural products.糖基化细菌天然产物的全面综述。
Chem Soc Rev. 2015 Nov 7;44(21):7591-697. doi: 10.1039/c4cs00426d.
3
Femtosecond laser-based mutagenesis strategy for micronomicin production enhancement of Micromonospora sagamiensis ATCC 21826.
基于飞秒激光的诱变策略提高 Micromonospora sagamiensis ATCC 21826 产生微诺霉素的能力。
World J Microbiol Biotechnol. 2013 Jun;29(6):1121-7. doi: 10.1007/s11274-013-1261-0. Epub 2013 Jan 25.